Tirzepatide, a recently approved medication, is creating significant excitement in the scientific community as a potential treatment for both type 2 diabetes and reducing body fat. This groundbreaking drug works by targeting two distinct receptors, GLP-1 and GIP, leading to improved blood sugar levels and substantial slimming in clinical trials . W